Holen Sie sich die Stockscreener-App
13.66
2.29%
-0.32
Finanzdaten der Rocket Pharmaceuticals Inc-Aktie (RCKT)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
6.47%
67.38
|
63.28 | 65.43 | 68.76 | 62.19 |
| Interest Income/Expense |
0.21%
0.471
|
0.47 | 0.469 | 0.468 | 0.468 |
| Operating Income/Loss |
6.47%
-67.38
|
-63.28 | -65.43 | -68.76 | -62.19 |
| Income/Loss From Continuing Operations Before Tax |
4.01%
-62.05
|
-59.66 | -61.90 | -65.70 | -58.34 |
| Income/Loss From Continuing Operations After Tax |
4.01%
-62.05
|
-59.66 | -61.90 | -65.70 | -58.34 |
|
Net Income/Loss
|
4.01%
-62.05
|
-59.66 | -61.90 | -65.70 | -58.34 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
2,876%
93.55
|
3.1433 | 82.64 | 80.47 | 79.45 |
| Diluted Average Shares |
2,876%
93.55
|
3.1433 | 82.64 | 80.47 | 79.45 |
| Basic Earnings Per Share |
6.45%
-0.66
|
-0.62 | -0.75 | -0.82 | -0.73 |
| Diluted Earnings Per Share |
6.45%
-0.66
|
-0.62 | -0.75 | -0.82 | -0.73 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
3.66%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):